These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 13204389
1. Pentapyrrolidinium bitartrate (M. & B. 2050A) in the treatment of hypertension; preliminary observations. GIFFORD RW, ALLEN EV, BIRKHEAD NC. Proc Staff Meet Mayo Clin; 1954 Sep 01; 29(18):496-508. PubMed ID: 13204389 [No Abstract] [Full Text] [Related]
2. [Treatment of arterial hypertension with M & B 2050A (pentapyrrolidinium bitartrate)]. FERNANDEZ FERRER O, MACIAS CASTRO I, LOPEZ DE LA VEGA R. Arch Hosp Univ; 1955 Sep 01; 7(2):113-9. PubMed ID: 13269266 [No Abstract] [Full Text] [Related]
3. Practical details of the treatment of hypertension by hexamethonium salts and by pentamethylene 1:5-bis-N-(N-methylpyrrolidinium) bitartrate (M. & B. 2050A). SMIRK FH. N Z Med J; 1953 Oct 01; 52(291):325-48. PubMed ID: 13119920 [No Abstract] [Full Text] [Related]
4. [Drug therapy of arterial hypertension; pentapyrrolidinium bitartrate (ansolysen), a new remedy for peroral use]. RØNNOV-JESSEN V. Ugeskr Laeger; 1954 Apr 15; 116(15):551-8. PubMed ID: 13169361 [No Abstract] [Full Text] [Related]
5. Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A). SMIRK FH. Lancet; 1953 Mar 07; 1(6758):457-64. PubMed ID: 13036030 [No Abstract] [Full Text] [Related]
6. Experience in the treatment of hypertension with pentapyrrolidinium (ansolysen) in a hypertension outpatient clinic. POMERANTZ HZ, BARSKY S, GORDON L, WENER J. Can Med Assoc J; 1957 Aug 15; 77(4):325-8. PubMed ID: 13446819 [No Abstract] [Full Text] [Related]
7. Therapy of hypertension with pentapyrrolidinium. KAINDL F, RUMMELHARDT K. Wien Z Inn Med; 1956 Nov 15; 37(11):465-70. PubMed ID: 13401791 [No Abstract] [Full Text] [Related]
8. [Pentapyrrolidinium tartrate in arterial hypertension]. MERLI A, MUSCARI A. Minerva Med; 1957 Sep 29; 48(78):3140-5. PubMed ID: 13483343 [No Abstract] [Full Text] [Related]
9. Comparison of effects on hypertension of hexamethonium and pentapyrrolidinium injected subcutaneously. BIRKHEAD NC, ALLEN EV. Proc Staff Meet Mayo Clin; 1954 Sep 01; 29(18):489-96. PubMed ID: 13204388 [No Abstract] [Full Text] [Related]
10. Renal haemodynamic effects of hypotensive drugs. II. Effects of oral maintenance therapy with pentapyrrolidinium bitartrate and reserpine. GOLDBERG B, MCDONALD L. Lancet; 1957 Jan 12; 272(6959):77-8. PubMed ID: 13386279 [No Abstract] [Full Text] [Related]
11. [Treatment of hypertension with hexamethonium salts and pentamethylene 1,5-bis(1-methylpyrrolidinium)-bitartrate]. SMIRK FH. Athena; 1954 Jan 12; 20(6-7):243-8. PubMed ID: 13198761 [No Abstract] [Full Text] [Related]
12. [Action of pyrroplegium bitartrate (ansolysen) on arterial hypertension; study of 27 cases]. JOLY F, BRIAL E. Presse Med (1893); 1958 Sep 17; 66(63):1415-8. PubMed ID: 13591268 [No Abstract] [Full Text] [Related]
13. [Treatment of hypertension with hexamethylammonium salts and pentamethylene-1,5-bis-N-(N-methylpyrrolidinium)-bitartrate; experience with 250 patients treated for a period of time from 3 months to 3 years and 8 months]. SMIRK FH. Medizinische; 1955 Apr 02; 14():485-90. PubMed ID: 14383073 [No Abstract] [Full Text] [Related]
15. [Treatment of hypertension with 3-methyl-pentapyrrolidinium]. MOELLER J. Med Klin; 1956 Aug 31; 51(35):1466-71. PubMed ID: 13358552 [No Abstract] [Full Text] [Related]
16. [Pentapyrrolidinium (ansolysen) therapy of hypertension]. PERSSON I. Ugeskr Laeger; 1954 Nov 11; 116(45):1601-3. PubMed ID: 13226509 [No Abstract] [Full Text] [Related]
20. [Observations on the treatment of arterial hypertension with hexamethonium with hydergine]. ROJAS VILLEGAS F, SILVA LAFRENTZ C, TOLEDO P, SILVA CLARK A, VERA G. Rev Med Chil; 1954 Mar 11; 82(3):132-7. PubMed ID: 13186421 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]